Steen Bonnema: Clinical Trials

4 trials sponsored by Steen Bonnema, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 1 Not applicable, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 21Completed 1
Phase 41Completed 1

Follow Steen Bonnema: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Selenium Supplementation in Autoimmune Thyroiditis
SelenoPRECISE, Placebo - Autoimmune Thyroiditis
Not applicableCompletedSteen Bonnema4152014-06-012023-10-31
Bone Structure and Strength Evaluated by Extreme-CT Scan Before and After Treatment of Hyper- and Hypothyroidism
Hyperthyroidism, Hypothyroidism
CompletedSteen Bonnema932012-02-012020-04-13
rhTSH, Radioiodine Uptake and Goiter Reduction Following 131I Therapy in Patients With Benign Nontoxic Nodular Goiter
Recombinant human thyrotropin (Thyrogen), recombinant human TSH, isotonic saline = placebo - Nodular Goiter
Phase 2CompletedSteen Bonnema902006-02-012013-12-04
Block-replacement Therapy During Radioiodine Therapy
MTZ+LT4, Methimazole - Toxic Nodular Goitre, Graves' Disease
Phase 4CompletedSteen Bonnema1002003-01-012013-12-04

Conditions studied

Goiter, Nodular (1)  ·  Graves Disease (1)  ·  Hyperthyroidism (1)  ·  Hypothyroidism (1)  ·  Osteoporosis (1)  ·  Thyroiditis, Autoimmune (1)

Interventions

Methimazole (1)  ·  Thyrotropin Alfa (1)

Countries

Denmark (4)

Top investigators

Jeppe Gram, MD, PhD (1)  ·  Kristian H Winther, MD (1)  ·  Nils J Knudsen, MD, DMSc (1)  ·  Per Cramon, MD (1)  ·  Steen J Bonnema, MD, DMSc (1)  ·  Steen J. Bonnema, MD (1)  ·  Steen J. Bonnema, MD, PhD (1)  ·  Torquil Watt, MD, PhD (1)  ·  Ulla Feldt-Rasmussen, MD, DMSc (1)

Results publications

PMID 20519346, PMID 21175612, PMID 24716668, PMID 33901280, PMID 34961921, PMID 36064878, PMID 38215286